Bivalent vaccines effectively protect mice against influenza A and respiratory syncytial viruses

Influenza and Respiratory Syncytial virus (RSV) infections together contribute significantly to the burden of acute lower respiratory tract infections. Despite the disease burden, no approved RSV vaccine is available. While approved vaccines are available for influenza, seasonal vaccination is requi...

Descripción completa

Detalles Bibliográficos
Autores principales: Raman, Sathya N. Thulasi, Zetner, Adrian, Hashem, Anwar M., Patel, Devina, Wu, Jianguo, Gravel, Caroline, Gao, Jun, Zhang, Wanyue, Pfeifle, Annabelle, Tamming, Levi, Parikh, Karan, Cao, Jingxin, Tam, Roger, Safronetz, David, Chen, Wangxue, Johnston, Michael J.W., Wang, Lisheng, Sauve, Simon, Rosu-Myles, Michael, Domselaar, Gary Van, Li, Xuguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Non-Neutralizing Protective Antibodies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171128/
https://www.ncbi.nlm.nih.gov/pubmed/36927227
http://dx.doi.org/10.1080/22221751.2023.2192821

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171128/
https://www.ncbi.nlm.nih.gov/pubmed/36927227
http://dx.doi.org/10.1080/22221751.2023.2192821

Ejemplares similares